Global Bioabsorbable Stents Market 2018-2023: Fueled by Rising Obese Population / Steep Growth in the Geriatric Population - ResearchAndMarkets.com

DUBLIN--()--The "Global Bioabsorbable Stents Market - Segmented by Type of Product, Application, Absorption Rate, End User, and Geography - Growth, Trends, and Forecast (2018 - 2023)" report has been added to ResearchAndMarkets.com's offering.

The global bioabsorbable stents market is expected to register a CAGR of 11% during the forecast period (2018 - 2023).

According to World Health Organization (WHO), cardiovascular diseases are the number one cause of death globally. In 2015, it is estimated that about 17.7 million people died because of cardiovascular diseases and in these deaths, it was estimated that 7.4 million people died because of coronary heart disease and 6.7 million people died of a stroke. Thus, a large number of people are already suffering from these cardiovascular diseases, and with the increase in population the number of people with cardiovascular diseases is expected to rise. This rise in the disease rate is also expected to increase the usage of stents, in turn, it is expected to drive the market during the forecast years. The changing lifestyles, rising obese population, and steep growth in the geriatric population are the major driving factors for the market growth.

Europe has the largest market share in the bioabsorbable stents market, followed by North America. Asia-Pacific is expected to have the highest growth rate in the forecast period, due to the increasing awareness among people about the procedure and the products. The US FDA has approved only one product, namely Abbott Absorb, and it is now commercially available in the US. However, several products are being developed, some are in clinical trials and others in various stages of development, which is an indication of a bright future for this market.

Key Developments in the Market

  • September 2017: Abbott Laboratories halted the global sales of their fully absorbable stent-Absorb Bioresorbable Vascular Scaffold (BVS).
  • April 2017: Reva Medical has secured a CE mark for its drug-eluting bioresorbable coronary scaffold.

Key Topics Covered

1. Introduction

2. Research Methodology

3. Executive Summary

4. Key Inferences

5. Market Overview

6. Drivers, Restraints, Opportunities and Challenges Analysis (DROC)

7. Market Segmentation

8. Competitive Landscape

9. Key Players

  • Abbott Laboratories
  • Kyoto Medical Planning Co. Ltd
  • Reva Medical
  • Elixir Medical Corporation
  • Amaranth Medical
  • Terumo Corporation
  • Arterius Limited
  • Biotronik
  • Xenogenics Corporation
  • Meril Life Sciences Pvt Ltd.

10. Future of the Market

For more information about this report visit https://www.researchandmarkets.com/research/92rc9r/global?w=4

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics: Stents

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics: Stents